Practical metabolomics in drug discovery

Importance of the field: Metabolomics is increasingly becoming an important field in the pharmaceutical industry to support the discovery and development of therapeutic agents. It allows the comprehensive and simultaneous profiling of hundreds of discrete biologically important molecules, including amino acids, sugars, lipids and exogenous substances from biological fluids and tissues. Metabolomics is the ‘omics’ field that most represents the interplay of internal biological regulation and external environmental influences on disease, thereby being of particular importance to disease mitigation and management. Areas covered in this review: Technological advances in the experimental work flow, analytical detection strategies and bioinformatics tools have enabled metabolomics studies to become increasingly comprehensive, robust and informative for the understanding of disease, drug action and the development of biomarkers. This review will focus on the practical aspects of metabolomics studies as they have been applied to the study of mammalian biological systems, specifically targeted to the steps of experimental design with regard to sample preparation, sample analysis and data analysis of both polar and non-polar metabolites. What the reader will gain: The reader will gain an overview of the field of metabolomics as it applies to drug development and the practical issues involved with experimental design. We will discuss the various methods of sample preparation and analysis as they apply to different classes of metabolites and highlight recent advances in the field that illustrate these methods. Take home message: The field of metabolomics is a rapidly expanding discipline that is being applied to various aspects of drug development. The large diversity of metabolites found in nature dictates that different methods be developed for the investigation of different classes of metabolites. As the field of metabolomics continues to mature, it is likely that it will play an increasingly important role in the characterization of disease and the future development of biomarkers to assess drug efficacy and safety.

[1]  Takahiro Suzuki,et al.  Development of a reverse-phase liquid chromatography electrospray ionization mass spectrometry method for lipidomics, improving detection of phosphatidic acid and phosphatidylserine. , 2008, Analytical biochemistry.

[2]  Thomas O Metz,et al.  High Resolution Separations and Improved Ion Production and Transmission in Metabolomics. , 2008, Trends in analytical chemistry : TRAC.

[3]  M. Wenk The emerging field of lipidomics , 2005, Nature Reviews Drug Discovery.

[4]  I. Wilson,et al.  D-Serine-induced nephrotoxicity: a HPLC-TOF/MS-based metabonomics approach. , 2005, Toxicology.

[5]  G. Siuzdak,et al.  Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. , 2006, Analytical chemistry.

[6]  J. Heijnen,et al.  Quantitative analysis of the microbial metabolome by isotope dilution mass spectrometry using uniformly 13C-labeled cell extracts as internal standards. , 2005, Analytical biochemistry.

[7]  Corey D. DeHaven,et al.  Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.

[8]  Rima Kaddurah-Daouk,et al.  Metabolomics tools for identifying biomarkers for neuropsychiatric diseases , 2009, Neurobiology of Disease.

[9]  Masaru Tomita,et al.  MathDAMP: a package for differential analysis of metabolite profiles , 2006, BMC Bioinformatics.

[10]  R. Dixon,et al.  Plant metabolomics: large-scale phytochemistry in the functional genomics era. , 2003, Phytochemistry.

[11]  T. Noda,et al.  MALDI-based imaging mass spectrometry revealed abnormal distribution of phospholipids in colon cancer liver metastasis. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  Jeffrey S. Forrester,et al.  Lipidomics: an analysis of cellular lipids by ESI-MS. , 2006, Methods.

[13]  D. Touboul,et al.  Application à la maladie de Fabry , 2006 .

[14]  Thomas Hankemeier,et al.  Analytical strategies in lipidomics and applications in disease biomarker discovery. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[15]  D. Pozo,et al.  Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics , 2008, Journal of cellular and molecular medicine.

[16]  R. Gerszten,et al.  Application of metabolomics to cardiovascular biomarker and pathway discovery. , 2008, Journal of the American College of Cardiology.

[17]  D. Wishart,et al.  The human cerebrospinal fluid metabolome. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[18]  N. Dib,et al.  Investigational new drug application (IND). , 2008, Journal of cardiovascular translational research.

[19]  Yiyu Cheng,et al.  A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus. , 2007, Journal of proteome research.

[20]  William J. Griffiths,et al.  Mass spectrometry: from proteomics to metabolomics and lipidomics. , 2009, Chemical Society reviews.

[21]  R. Abagyan,et al.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. , 2006, Analytical chemistry.

[22]  Richard D. Smith,et al.  Charge competition and the linear dynamic range of detection in electrospray ionization mass spectrometry , 2004, Journal of the American Society for Mass Spectrometry.

[23]  David S. Wishart,et al.  HMDB: a knowledgebase for the human metabolome , 2008, Nucleic Acids Res..

[24]  D. Wishart Applications of Metabolomics in Drug Discovery and Development , 2008, Drugs in R&D.

[25]  N. Serkova,et al.  Metabolomics of cancer. , 2009, Methods in molecular biology.

[26]  T. Veenstra,et al.  Utility of separation science in metabolomic studies. , 2008, Journal of separation science.

[27]  David S. Wishart,et al.  MetaboAnalyst: a web server for metabolomic data analysis and interpretation , 2009, Nucleic Acids Res..

[28]  A. Alpert Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. , 1990, Journal of chromatography.

[29]  M. Karas,et al.  Effect of different solution flow rates on analyte ion signals in nano-ESI MS, or: when does ESI turn into nano-ESI? , 2003, Journal of the American Society for Mass Spectrometry.

[30]  J. Heijnen,et al.  Quantitative evaluation of intracellular metabolite extraction techniques for yeast metabolomics. , 2009, Analytical chemistry.

[31]  M. Tomita,et al.  Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. , 2003, Journal of proteome research.

[32]  G. Churchill Using ANOVA to analyze microarray data. , 2004, BioTechniques.

[33]  P. Meikle,et al.  Urinary lipid profiling for the identification of fabry hemizygotes and heterozygotes. , 2005, Clinical chemistry.

[34]  M. Moon,et al.  Shotgun analysis of phospholipids from mouse liver and brain by nanoflow liquid chromatography/tandem mass spectrometry. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[35]  J. Peter-Katalinic,et al.  Fully automated chip-based mass spectrometry for complex carbohydrate system analysis. , 2004, Analytical chemistry.

[36]  Susumu Goto,et al.  The KEGG databases at GenomeNet , 2002, Nucleic Acids Res..

[37]  M. Moon,et al.  Profiling of human urinary phospholipids by nanoflow liquid chromatography/tandem mass spectrometry. , 2008, The Analyst.

[38]  Dukjin Kang,et al.  Nanoflow liquid chromatography-tandem mass spectrometry for the characterization of intact phosphatidylcholines from soybean, bovine brain, and liver. , 2006, Journal of chromatography. A.

[39]  I. Wilson,et al.  Metabonomic Studies Comparing Capillary and Conventional HPLC-oa-TOF MS for the Analysis of Urine from Zucker Obese Rats , 2005 .

[40]  Xianlin Han,et al.  Toward fingerprinting cellular lipidomes directly from biological samples by two-dimensional electrospray ionization mass spectrometry. , 2004, Analytical biochemistry.

[41]  Peer Bork,et al.  KEGG Atlas mapping for global analysis of metabolic pathways , 2008, Nucleic Acids Res..

[42]  Pedro Mendes,et al.  Emerging bioinformatics for the metabolome , 2002, Briefings Bioinform..

[43]  D. Touboul,et al.  [Imaging mass spectrometry: a new tool for the analysis of skin biopsy. Application in Fabry's disease]. , 2006, Annales pharmaceutiques francaises.

[44]  J. Alvarez,et al.  Separation of acidic and neutral lipids by aminopropyl-bonded silica gel column chromatography. , 1992, Journal of chromatography.

[45]  G. Kong,et al.  Quantitative profiling of phosphatidylcholine and phosphatidylethanolamine in a steatosis/fibrosis model of rat liver by nanoflow liquid chromatography/tandem mass spectrometry. , 2008, Journal of chromatography. A.

[46]  A. Häkkinen,et al.  Adipose Tissue Inflammation and Increased Ceramide Content Characterize Subjects With High Liver Fat Content Independent of Obesity , 2007, Diabetes.

[47]  Y. Oda,et al.  Polar anionic metabolome analysis by nano-LC/MS with a metal chelating agent. , 2009, Analytical chemistry.

[48]  John T. Wei,et al.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.

[49]  Ryo Taguchi,et al.  Global analysis of triacylglycerols including oxidized molecular species by reverse-phase high resolution LC/ESI-QTOF MS/MS. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[50]  Stephen J. Bruce,et al.  Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry. , 2009, Analytical chemistry.

[51]  Matej Oresic,et al.  Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis , 2007, BMC Systems Biology.

[52]  D. Steinberg Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part II: the early evidence linking hypercholesterolemia to coronary disease in humans. , 2005, Journal of lipid research.

[53]  Xianlin Han,et al.  Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. , 2003, Journal of lipid research.

[54]  G. Siuzdak,et al.  Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and exogenous metabolites in human serum. , 2006, Analytical chemistry.

[55]  Mark R Viant,et al.  Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy. , 2008, Analytical biochemistry.

[56]  Takao Shimizu,et al.  Basic analytical systems for lipidomics by mass spectrometry in Japan. , 2007, Methods in enzymology.

[57]  B. Hammock,et al.  Mass spectrometry-based metabolomics. , 2007, Mass spectrometry reviews.

[58]  U. Sauer,et al.  Cross-platform comparison of methods for quantitative metabolomics of primary metabolism. , 2009, Analytical chemistry.

[59]  J. Nicholson,et al.  Novel application of reversed-phase UPLC-oaTOF-MS for lipid analysis in complex biological mixtures: a new tool for lipidomics. , 2007, Journal of proteome research.

[60]  Y. Oda,et al.  Quantitative profiling of polar cationic metabolites in human cerebrospinal fluid by reversed-phase nanoliquid chromatography/mass spectrometry. , 2009, Analytical chemistry.

[61]  W. Weckwerth Metabolomics in systems biology. , 2003, Annual review of plant biology.

[62]  B. Sas,et al.  Efficient method for (lyso)phospholipid class separation by high-performance liquid chromatography using an evaporative light-scattering detector. , 1999, Journal of chromatography. A.

[63]  Julian L Griffin,et al.  Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders. , 2006, Pharmacogenomics.

[64]  Donald G Robertson,et al.  Metabonomics in toxicology: a review. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[65]  I. Wilson,et al.  Cyclosporin A-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field 1H NMR spectroscopy, HPLC-TOF/MS and chemometrics. , 2004, Journal of pharmaceutical and biomedical analysis.

[66]  Huan He,et al.  Method for lipidomic analysis: p53 expression modulation of sulfatide, ganglioside, and phospholipid composition of U87 MG glioblastoma cells. , 2007, Analytical chemistry.

[67]  M. Orešič,et al.  Data processing for mass spectrometry-based metabolomics. , 2007, Journal of chromatography. A.

[68]  G. Berry,et al.  Brain phosphoinositide extraction, fractionation, and analysis by MALDI-TOF MS. , 2009, Methods in molecular biology.

[69]  B. Ganter,et al.  Emerging applications of network and pathway analysis in drug discovery and development. , 2008, Current opinion in drug discovery & development.

[70]  Georgios Theodoridis,et al.  UPLC-MS-based analysis of human plasma for metabonomics using solvent precipitation or solid phase extraction. , 2009, Journal of proteome research.

[71]  Xianlin Han,et al.  Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. , 2005, Mass spectrometry reviews.

[72]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[73]  Jens Stoye,et al.  MeltDB: a software platform for the analysis and integration of metabolomics experiment data , 2008, Bioinform..

[74]  I. Wilson,et al.  High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. , 2005, Journal of proteome research.

[75]  Aldons J. Lusis,et al.  A thematic review series: systems biology approaches to metabolic and cardiovascular disorders , 2006, Journal of Lipid Research.

[76]  Xianlin Han,et al.  Shotgun lipidomics of cardiolipin molecular species in lipid extracts of biological samples Published, JLR Papers in Press, January 31, 2006. , 2006, Journal of Lipid Research.

[77]  S. Williams,et al.  A comparison of cell and tissue extraction techniques using high‐resolution 1H‐NMR spectroscopy , 2002, NMR in biomedicine.

[78]  A. Watson,et al.  Thematic Review Lipidomics: a Global Approach to Lipid Analysis in Biological Systems , 2022 .

[79]  M. Wenk,et al.  Lipid-based biomarkers for cancer. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[80]  S. Friend,et al.  A network view of disease and compound screening , 2009, Nature Reviews Drug Discovery.

[81]  Oliver Fiehn,et al.  Analysis of highly polar compounds of plant origin: combination of hydrophilic interaction chromatography and electrospray ion trap mass spectrometry. , 2002, Analytical biochemistry.

[82]  Oliver Fiehn,et al.  Metabolomic database annotations via query of elemental compositions: Mass accuracy is insufficient even at less than 1 ppm , 2006, BMC Bioinformatics.

[83]  J. German,et al.  Metabolomics for assessment of nutritional status , 2009, Current opinion in clinical nutrition and metabolic care.

[84]  Xianlin Han,et al.  Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis , 2002, Journal of neurochemistry.

[85]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[86]  N. M. Faber,et al.  How to avoid over-fitting in multivariate calibration--the conventional validation approach and an alternative. , 2007, Analytica chimica acta.

[87]  Xianlin Han,et al.  Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes , 2005, Expert review of proteomics.

[88]  D. Botstein,et al.  Singular value decomposition for genome-wide expression data processing and modeling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[89]  Takao Shimizu,et al.  Focused lipidomics by tandem mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[90]  Takao Shimizu,et al.  Rapid and selective identification of molecular species in phosphatidylcholine and sphingomyelin by conditional neutral loss scanning and MS3. , 2004, Rapid communications in mass spectrometry : RCM.

[91]  M. Klapa,et al.  Standardizing GC-MS metabolomics. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[92]  Takao Shimizu,et al.  A shotgun tandem mass spectrometric analysis of phospholipids with normal-phase and/or reverse-phase liquid chromatography/electrospray ionization mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[93]  D. Pleasure,et al.  Microdissection of peripheral nerve Collagen and lipid distribution with morphological correlation , 1976, Journal of the Neurological Sciences.

[94]  Ken Aoshima,et al.  Quantitative phosphorus metabolomics using nanoflow liquid chromatography-tandem mass spectrometry and culture-derived comprehensive global internal standards. , 2009, Analytical chemistry.

[95]  Giuseppe Musumarra,et al.  A Bioinformatic Approach to the Identification of Candidate Genes for the Development of New Cancer Diagnostics , 2003, Biological chemistry.